Overview

Antibiotic Prophylaxis in Rhinoplasty

Status:
Enrolling by invitation

Trial end date:
2024-04-20

Target enrollment:

Participant gender:

Summary

This study compares the efficacy of a single intra-operative (intravenous) dose of "cephalexin" (first generation cephalosporin) or "clindamycin" (lincosamides), alone versus both intra-operative (intravenous) dose of "cephalexin" (first generation cephalosporin) or "clindamycin" (lincosamides) and postoperative oral dose of "cephalexin" or "clindamycin" use in nasal surgery.

Phase:

Phase 3

Details

Lead Sponsor:

Stanford University

Collaborators:

Duke University
Harvard University
Université de Montréal
University of Kansas Medical Center
University of Washington
Vanderbilt University School of Medicine
Washington University School of Medicine

Treatments:

Anti-Bacterial Agents
Antibiotics, Antitubercular
Cephalexin
Clindamycin
Clindamycin palmitate
Clindamycin phosphate